(Q34273624)

1 August 2017

1 reference

title

Pneumococcal disease in the elderly: what is preventing vaccine efficacy? (English)

1 reference

1 August 2017

Rubins JB

1

1 reference

1 August 2017

Janoff EN

series ordinal

2

1 reference

1 August 2017

language of work or name

1 reference

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

18

1 reference

1 August 2017

5

1 reference

1 August 2017

305-311

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200118050-00001

1 August 2017

0 references

cites work

Antibody response of pneumococcal vaccine: need for booster dosing?

1 reference

12 December 2020

From the Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among adults aged > or = 65 years--United States, 1997

1 reference

12 December 2020

Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments

1 reference

12 December 2020

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

1 reference

12 December 2020

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease

1 reference

12 December 2020

Failure of intensive care unit support to influence mortality from pneumococcal bacteremia

1 reference

12 December 2020

Pneumococcal bacteremia--no change in mortality in 30 years: analysis of 104 cases and review of the literature

1 reference

12 December 2020

Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment

1 reference

12 December 2020

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

12 December 2020

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

12 December 2020

Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly

1 reference

12 December 2020

Pneumococcal vaccine: clinical efficacy and effectiveness

1 reference

12 December 2020

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria

1 reference

12 December 2020

Anti-pneumococcal antibody response in normal subjects: a meta-analysis

1 reference

12 December 2020

Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons

1 reference

12 December 2020

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial

1 reference

12 December 2020

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

1 reference

12 December 2020

Pneumococcal vaccine efficacy in selected populations in the United States

1 reference

12 December 2020

Prevention of pneumococcal pneumonia by vaccination

1 reference

12 December 2020

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

1 reference

12 December 2020

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

1 reference

12 December 2020

Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides

1 reference

12 December 2020

Antibody to Capsular Polysaccharides of Streptococcus pneumoniae: Prevalence, Persistence, and Response to Revaccination

1 reference

12 December 2020

Effect of age, sex and smoking habits on pneumococcal antibodies in an elderly population.

1 reference

12 December 2020

The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae

1 reference

12 December 2020

Protective Efficacy of Pneumococcal Polysaccharide Vaccines

1 reference

12 December 2020

Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial

1 reference

12 December 2020

Impaired antibody responses to pneumococcal polysaccharide in elderly patients with low serum vitamin B12 levels.

1 reference

12 December 2020

Immune function and vaccine responses in healthy advanced elderly patients

1 reference

12 December 2020

The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly

1 reference

12 December 2020

Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity

1 reference

12 December 2020

Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults

1 reference

12 December 2020

Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.

1 reference

12 December 2020

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

1 reference

12 December 2020

Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study

1 reference

12 December 2020

Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era.

1 reference

12 December 2020

Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly

1 reference

12 December 2020

Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination

1 reference

12 December 2020

Specific immunoglobulin-class antibody responses in the elderly before and after 14-valent pneumococcal vaccine

1 reference

12 December 2020

A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

1 reference

12 December 2020

IgG subclasses of pneumococcal antibodies--effect of allotype G2m(n)

1 reference

12 December 2020

10.2165/00002512-200118050-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference